KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Encompass Health (EHC) Net Cash Flow (2016 - 2025)

Encompass Health (EHC) has disclosed Net Cash Flow for 17 consecutive years, with $9.2 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Net Cash Flow rose 112.14% year-over-year to $9.2 million, compared with a TTM value of -$20.2 million through Dec 2025, down 206.88%, and an annual FY2025 reading of -$20.2 million, down 206.88% over the prior year.
  • Net Cash Flow was $9.2 million for Q4 2025 at Encompass Health, up from -$43.7 million in the prior quarter.
  • Across five years, Net Cash Flow topped out at $102.1 million in Q2 2022 and bottomed at -$156.5 million in Q2 2021.
  • Average Net Cash Flow over 5 years is -$10.4 million, with a median of $4.4 million recorded in 2025.
  • Peak annual rise in Net Cash Flow hit 339.04% in 2022, while the deepest fall reached 536.47% in 2022.
  • Year by year, Net Cash Flow stood at -$54.6 million in 2021, then grew by 7.14% to -$50.7 million in 2022, then grew by 27.02% to -$37.0 million in 2023, then tumbled by 104.86% to -$75.8 million in 2024, then surged by 112.14% to $9.2 million in 2025.
  • Business Quant data shows Net Cash Flow for EHC at $9.2 million in Q4 2025, -$43.7 million in Q3 2025, and $14.6 million in Q2 2025.